Acquiring Company
Vivo Infusion
Acquired Company
Specialty Infusion
Description
Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services announced today it has acquired Specialty Infusion, an industry leader in ambulatory infusion and specialty pharmacy services, dedicated to convenient and affordable solutions for infusion patients in 14 ambulatory infusion centers in New York, Massachusetts, and New Jersey. With this acquisition, Vivo Infusion will advance to a combined 55 ambulatory infusion centers across ten states. Financial terms of the transaction were not disclosed.
Quick answer
Vivo Infusion is acquiring Specialty Infusion, announced June 20, 2023. Vivo Infusion is based in Lakewood, Colorado, United States.
- How much did Vivo Infusion pay for Specialty Infusion?
- The deal value was not disclosed.
- What does Vivo Infusion do?
- Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions.
- Where are Vivo Infusion and Specialty Infusion based?
- Vivo Infusion is based in Lakewood, Colorado, United States.
- Who are the decision-makers at Vivo Infusion?
- Fundz holds 1 contact at Vivo Infusion. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Serb Pharmaceuticals Acquires Vistogard® And Xuriden® From Wellstat Therapeutics (July 13, 2023)
- Astellas Completes Acquisition Of Iveric Bio (July 11, 2023)
- Lilly To Acquire Sigilon Therapeutics (June 29, 2023)
- Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology (June 20, 2023)
- Ironwood And Vectivbio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of Vectivbio (June 16, 2023)
Who to call at Vivo Infusion, and when
When Vivo Infusion changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Vivo Infusion raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vivo Infusion, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vivo Infusion. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vivo Infusion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Specialty Infusion?
Specialty Infusion was acquired by Vivo Infusion, based in Lakewood. The deal was reported on June 20, 2023. Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions. Vivo Infusion is privately held and operates in Biotechnology.
When did Vivo Infusion acquire Specialty Infusion?
Vivo Infusion's acquisition of Specialty Infusion was reported on June 20, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Specialty Infusion do?
Specialty Infusion is a leading provider of ambulatory infusion and specialty pharmacy services, designed to safe, convenient, and affordable care for infusion patients to patients in New York, Massachusetts, and New Jersey. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.